STOCKSExpecting Ziopharm Shares To Run Into Phase III Data At Month's EndBy Mark MessierMar 4, 2013 7:00 AM EST
STOCKSAlexza Pharma: Run-Up Trade Into December's Approval DecisionsBy Mark MessierNov 20, 2012 8:03 AM EST
STOCKSHow to Prep for the Inevitable Bursting of the Biotech Stock BubbleBy Mark MessierOct 17, 2012 7:00 AM EDT
STOCKSAP Pharma, Delcath Systems: FDA 'Acceptance' Run-Up TradesBy Mark MessierOct 9, 2012 7:05 AM EDT
STOCKSAcadia Pharma, Sarepta Therapeutics: How to Trade Into Trial ResultsBy Mark MessierSep 19, 2012 7:31 AM EDT
